, Tracking Stock Market Picks
Enter Symbol:

down 99.95 %

AMERICAN ORIENTL BIO (AOB) rated Buy with price target $8 by Merriman Curhan Ford

Posted on: Monday,  Jan 12, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy AMERICAN ORIENTL BIO (OTCBB: AOBI) on 01/12/2009, when the stock price was $2630.25.
Since then, AMERICAN ORIENTL BIO has lost 99.96% as of 08/12/2015's recent price of $1.17.
If you would have followed this Merriman Curhan Ford's recommendation on AOBI, you would have lost 99.95% of your investment in 2403 days.

American Oriental Bioengineering, Inc. (AOB) is an integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. The Company?s business comprises prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA). The Company sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and cities in China. During the year ended December 31, 2008, AOB marketed over 60 pharmaceutical products in China. On October 18, 2008, the Company acquired Nuo Hua Investment Company Limited. On October 20, 2008, the Company acquired GuangXi HuiKe Pharmaceutical Research and Development Co., Ltd.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/12/2009 8:25 AM Buy
2,630.25 4,008.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy